your market intelligence analyst
Search Results
501 results
Your search is now limited to «Novartis» expert search.
Channel NewsAsia (Singapore) 10/22/2019 10:57
Novartis data suggest payers getting breaks on gene therapy Zolgensma.
More from Channel NewsAsia (Singapore):
FiercePharmaManufacturing 10/22/2019 10:57
Additionally, Novartis will have the AveXis head of quality assurance (QA) compliance sit on an extended Novartis QA Compliance extended leadership team.
More from FiercePharmaManufacturing:
STAT 10/22/2019 07:35
Zolgensma, a lifesaving treatment for infants and the world’s most expensive drug, has been used to treat 100 patients since its launch and brought in $160 million for its maker Novartis last quarter, beating analysts’ expectations.
More from STAT:
Seeking Alpha 10/22/2019 06:53
The following slide deck was published by Novartis AG in conjunction with their 2019 Q3 earnings call.
More from Seeking Alpha:
ENDPOINTS 10/22/2019 06:13
Failed PhIII fevipiprant trials pour more cold water on Novartis’ blockbuster R&D engine – Endpoints News.
More from ENDPOINTS:
FierceMedicalDevices 10/22/2019 03:46
Novartis’ asthma drug fails in phase 3, raising doubts about Gossamer’s prospects.
More from FierceMedicalDevices:
SmartMoney 10/22/2019 01:41
Novartis AG said Tuesday that net income rose 8% in the third quarter as it benefited from growing sales across its drug portfolio.
More from SmartMoney:
Novartis International AG 10/22/2019 01:00
Media Release. | |
More from Novartis International AG:
GlobeNewswire 10/22/2019 01:00
Financials In order to comply with International Financial Reporting Standards (IFRS), Novartis has separated the Group’s reported financial data for the current and prior years into “continuing” and “discontinued” operations.
More from GlobeNewswire:
MobiHealthNews 10/16/2019 10:28
Novartis is cutting off its digital therapeutics partnership with Pear Therapeutics.
More from MobiHealthNews:
FierceBiotech 10/16/2019 09:28
RELATED: Novartis' Sandoz goes digital from back office to 'not just apps,' therapeutics Novartis recently announced a partnership with Microsoft that aims to bring artificial intelligence tools to the desks of every research associate.
More from FierceBiotech:
(MENAFN - Market Research Explore) The Global Inhalation & Nasal Spray Generic Drugs Market research report focuses on exploring the developments and growth strategies of the globa...
More from Middle East North Africa Financial Network (MENAFN):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications